arrow
M

Myung-Shin Sim

university of california
H指数:41
被引数:6,120

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct inflammatory marker profiles of adolescents and young adults among the HIV risk, infection, and treatment spectrum

青少年和年轻人在HIV风险、感染和治疗谱中的不同炎症标志物谱

2026-09-250
OAAI
Posttranscriptional control of hepatic CEACAM13′UTR by human antigen R (HuR) mitigates sterile liver inflammation

转录后对肝源性CEACAM13′UTR的控制通过人抗原R(HuR)缓解无菌性肝炎症

2025-09-230
PRE
Tumour extracellular vesicle surface Protein-mRNA integration assay for early detection of epithelial ovarian cancer

肿瘤细胞外囊泡表面蛋白-mRNA整合检测法用于上皮性卵巢癌的早期诊断

2025-08-120
PREAI
Impact of postoperative fluorodeoxyglucose positron emission tomography/computed tomography on adjuvant head and neck cancer treatment

术后氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描对头颈癌辅助治疗的影响

2025-08-010
PRE
Identification of Tumor-Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma (Adv. Sci. 21/2025)

鉴定肿瘤特异性表面蛋白能够实现外泌体亚型的量化,以早期检测胰腺导管腺癌 (Adv. Sci. 21/2025)

2025-06-050
OA
Extracellular vesicle digital scoring assay for assessment of treatment responses in hepatocellular carcinoma patients

细胞外囊泡数字评分检测法评估肝细胞癌患者治疗反应

2025-05-010
OA
Identification of Tumor-Specific Surface Proteins Enables Quantification of Extracellular Vesicle Subtypes for Early Detection of Pancreatic Ductal Adenocarcinoma

鉴定肿瘤特异性表面蛋白能够实现外泌体亚型的定量,以用于早期检测胰腺导管腺癌

2025-03-250
OAAI
University of Washington Quality of Life subdomain outcomes after treatment of sinonasal malignancy: A prospective, multicenter study
2024-06-171
OA
SNOT-22 subdomain outcomes following treatment for sinonasal malignancy: A prospective, multicenter study

鼻窦恶性肿瘤治疗后sno-22子域结果: 一项前瞻性、多中心研究

2024-02-194
PRE
Long-term quality of life after treatment in sinonasal malignancy: A prospective, multicenter study
2023-05-0911
PRE
HCC EV ECG score: An extracellular vesicle-based protein assay for detection of early-stage hepatocellular carcinoma

HCC EV ECG评分: 一种基于细胞外囊泡的蛋白质测定方法,用于检测早期肝细胞癌

2023-02-1740
OA